BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28054838)

  • 1. IL-6 Mediates Macrophage Infiltration after Irradiation via Up-regulation of CCL2/CCL5 in Non-small Cell Lung Cancer.
    Wang X; Yang X; Tsai Y; Yang L; Chuang KH; Keng PC; Lee SO; Chen Y
    Radiat Res; 2017 Jan; 187(1):50-59. PubMed ID: 28054838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the chemokines MCP-1/CCL2 and RANTES/CCL5 is differentially regulated by infiltrating inflammatory cells.
    Haberstroh U; Pocock J; Gómez-Guerrero C; Helmchen U; Hamann A; Gutierrez-Ramos JC; Stahl RA; Thaiss F
    Kidney Int; 2002 Oct; 62(4):1264-76. PubMed ID: 12234296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 signaling contributes to cisplatin resistance in non-small cell lung cancer via the up-regulation of anti-apoptotic and DNA repair associated molecules.
    Duan S; Tsai Y; Keng P; Chen Y; Lee SO; Chen Y
    Oncotarget; 2015 Sep; 6(29):27651-60. PubMed ID: 26313152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor α promotes lung cancer cell invasion via increase of and cross-talk with infiltrated macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling pathways.
    He M; Yu W; Chang C; Miyamoto H; Liu X; Jiang K; Yeh S
    Mol Oncol; 2020 Aug; 14(8):1779-1799. PubMed ID: 32356397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.
    Chen JJ; Yao PL; Yuan A; Hong TM; Shun CT; Kuo ML; Lee YC; Yang PC
    Clin Cancer Res; 2003 Feb; 9(2):729-37. PubMed ID: 12576442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCL2 conditionally determines CCL22-dependent Th2-accumulation during TGF-β-induced breast cancer progression.
    Mandal PK; Biswas S; Mandal G; Purohit S; Gupta A; Majumdar Giri A; Roy Chowdhury S; Bhattacharyya A
    Immunobiology; 2018 Feb; 223(2):151-161. PubMed ID: 29107385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate signaling mechanisms controlling Mycobacterium chelonae-mediated CCL2 and CCL5 expression in macrophages.
    Kim YS; Kim JH; Woo M; Kim TS; Sohn KM; Lee YH; Jo EK; Yuk JM
    J Microbiol; 2015 Dec; 53(12):864-74. PubMed ID: 26626357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-17 potently increases non-small cell lung cancer growth.
    Wei L; Wang H; Yang F; Ding Q; Zhao J
    Mol Med Rep; 2016 Feb; 13(2):1673-80. PubMed ID: 26708832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer.
    Lee SO; Yang X; Duan S; Tsai Y; Strojny LR; Keng P; Chen Y
    Oncotarget; 2016 Feb; 7(6):6626-38. PubMed ID: 26675547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer.
    Svensson S; Abrahamsson A; Rodriguez GV; Olsson AK; Jensen L; Cao Y; Dabrosin C
    Clin Cancer Res; 2015 Aug; 21(16):3794-805. PubMed ID: 25901081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CtBP1 promotes tumour-associated macrophage infiltration and progression in non-small-cell lung cancer.
    Wang Z; Zhao Y; Xu H; Liang F; Zou Q; Wang C; Jiang J; Lin F
    J Cell Mol Med; 2020 Oct; 24(19):11445-11456. PubMed ID: 32910558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression.
    Fujimoto H; Sangai T; Ishii G; Ikehara A; Nagashima T; Miyazaki M; Ochiai A
    Int J Cancer; 2009 Sep; 125(6):1276-84. PubMed ID: 19479998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma.
    Zhang Y; Du W; Chen Z; Xiang C
    Exp Cell Res; 2017 Oct; 359(2):449-457. PubMed ID: 28830685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory response of TLR4 deficient spleen macrophages (CRL 2471) to Brucella abortus S19 and an isogenic ΔmglA deletion mutant.
    Jacob J; Makou P; Finke A; Mielke M
    Int J Med Microbiol; 2016 May; 306(3):141-51. PubMed ID: 26946956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-C Motif Chemokine 5 Attenuates Angiotensin II-Dependent Kidney Injury by Limiting Renal Macrophage Infiltration.
    Rudemiller NP; Patel MB; Zhang JD; Jeffs AD; Karlovich NS; Griffiths R; Kan MJ; Buckley AF; Gunn MD; Crowley SD
    Am J Pathol; 2016 Nov; 186(11):2846-2856. PubMed ID: 27640148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-box transcription factor Brachyury in lung cancer cells inhibits macrophage infiltration by suppressing CCL2 and CCL4 chemokines.
    Chen S; Jiao J; Jiang D; Wan Z; Li L; Li K; Xu L; Zhou Z; Xu W; Xiao J
    Tumour Biol; 2015 Aug; 36(8):5881-90. PubMed ID: 25744730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EZH2 enhances expression of CCL5 to promote recruitment of macrophages and invasion in lung cancer.
    Xia L; Zhu X; Zhang L; Xu Y; Chen G; Luo J
    Biotechnol Appl Biochem; 2020 Nov; 67(6):1011-1019. PubMed ID: 31855281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway.
    Wang X; Wang Y; Xiao G; Wang J; Zu L; Hao M; Sun X; Fu Y; Hu G; Wang J
    Oncotarget; 2016 May; 7(21):30350-64. PubMed ID: 27107418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor 1α (HIF-1α) and reactive oxygen species (ROS) mediates radiation-induced invasiveness through the SDF-1α/CXCR4 pathway in non-small cell lung carcinoma cells.
    Gu Q; He Y; Ji J; Yao Y; Shen W; Luo J; Zhu W; Cao H; Geng Y; Xu J; Zhang S; Cao J; Ding WQ
    Oncotarget; 2015 May; 6(13):10893-907. PubMed ID: 25843954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer.
    Pasquier J; Gosset M; Geyl C; Hoarau-Véchot J; Chevrot A; Pocard M; Mirshahi M; Lis R; Rafii A; Touboul C
    Mol Cancer; 2018 Feb; 17(1):47. PubMed ID: 29455640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.